Fundamental dimension Equity attribute | BCMLLeader $30.45▼-4.55% Cap $332.5MP/E 36.3x QuantScore52/100 | CBANPeer $20.36▲+0.54% Cap $432.1MP/E 12.3x QuantScore39/100 | CZNCPeer $27.75▲+4.17% Cap $497.7MP/E 14.0x QuantScore40/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
57/100 |
83/100 |
71/100 |
Valuation Multiples, PEG & DCF upside | 66/100 | 50/100 | 72/100 |
Health Piotroski, Altman Z, leverage & liquidity | 40/100 | 21/100 | 33/100 |
Growth Revenue / earnings growth & margins | 32/100 | 39/100 | 24/100 |
Sentiment Analyst ratings, targets & revisions | 63/100 | 0/100 | 0/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 36.3x | 12.3x | 14.0x |
Forward P/E (next FY) | 14.9x | 10.1x | 12.8x |
EV / EBITDA (TTM) | 5.6x | 22.3x | 14.1x |
Price / Sales | 2.5x | 2.7x | 2.8x |
Price / Free Cash Flow | 12.5x | 19.2x | 11.0x |
PEG ratio | -0.60 | 2.79 | 1.12 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 4 / 9 | 7 / 9 |
Altman Z-Score | -0.60 (Distress) | 0.20 (Distress) | -0.48 (Distress) |
Total debt / equity | 0.06 | 0.60 | 0.48 |
Quick ratio | 0.2x | 0.4x | 0.2x |
Interest coverage | 0.4x | 0.3x | 0.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.0% | +5.4% | -0.8% |
Net income growth YoY | +1.3% | +18.4% | -9.8% |
Gross margin (TTM) | 68.8% | 59.2% | 57.5% |
Operating margin (FY) | 23.2% | 18.9% | 18.6% |
FCF margin (FY) | 21.2% | -3.7% | 19.5% |
5. Trailing price performancePrice change over period |
1M return | +0.8% | -1.8% | +8.0% |
3M return | -3.9% | -6.8% | +14.0% |
6M return | +3.5% | +2.4% | +20.0% |
Year to date | +3.6% | +14.3% | +37.6% |
1Y return | +9.7% | +21.9% | +42.0% |
3Y return | +56.2% | +112.3% | +55.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $21.42 -29.7% premium | $7.24 -64.4% premium | $12.34 -55.5% premium |
Wall Street consensus target | $34.00 +11.7% · range $34.00–$34.00 | — — | $23.50 -15.3% · range $23.50–$23.50 |
Consensus stance | 80% Buy20% Hold0% Sell | 0% Buy100% Hold0% Sell | 0% Buy100% Hold0% Sell |